Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McIntosh/Shays hearing on FDA device program slated for June 29.

This article was originally published in The Gray Sheet

Executive Summary

MCINTOSH/SHAYS HEARING ON FDA DEVICE PROGRAM SLATED FOR JUNE 29, according to staffers. Both Congressmen serve on the House Government Reform and Oversight Committee, with Rep. David McIntosh (R-Ind.) chairing the National Economic Growth Subcommittee, and Rep. Christopher Shays (R-Conn.) heading up the Human Resources Subcommittee. Specific elements of the device program to be examined at the joint subcommittee hearing have not yet been determined, staffers say, and witnesses have not yet been scheduled.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel